Characterization of receptor interaction and transcriptional repression by the corepressor SMRT

Molecular Endocrinology

Volumn 11, Issue 13, 1997, Pages 2025-2037

  Li, Hui ^a   Leo, Christopher ^a   Schroen, Daniel J ^a   Chen, J Don ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA;

EID: 0030784510     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.13.0028     Document Type: Article

References (59)

1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
2. Mangelsdorf DJ, Evans RM 1995 The RXR heterodimers and orphan receptors. Cell 83:841-850
3. Kastner P, Mark M, Chambon P 1995 Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869
4. Beato M, Herrlich P, Schültz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
5. Yu VC, Delsert C, Anderson B, Holloway JM, Devary OV, Narr AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXRb: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266
6. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM 1992 Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446-449
7. Baniahmad A, Kohne AC, Renkawitz R 1992 A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. Cell 11:1015-1023
8. Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai MJ, O'Malley BW 1995 The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 15:76-86
9. Holloway JM, Glass CK, Adler S, Nelson CA, Rosenfeld MG 1990 The C′-terminal interaction domain of the thyroid hormone receptor confers the ability of the DNA site to dictate positive or negative transcriptional activity. Proc Natl Acad Sci USA 87:8160-8164
10. Renkawitz R 1993 Repression mechanisms of v-ERBA and other members of the steroid receptor superfamily. Ann NY Acad Sci 684:1-10
11. Wong J, Shi YB, Wolffe AP 1995 A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor. Genes Dev 9:2696-2711
12. Damm K, Thompson CC, Evans RM 1989 Protein encoded by v-erbA functions as a thyroid hormone receptor antagonist. Nature 339:593-597
13. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B 1986 The erbA protein is a high affinity receptor for thyroid hormone. Nature 324: 635-640
14. Damm K, Heyman R, Umesono K, Evans RM 1993 Functional inhibition of retinoic acid response by dominant negative RAR mutants. Proc Natl Acad Sci USA 90:2989-2993
15. Imakado S, Bickenbach JR, Bundman DS, Rothnagel JA, Attar PS, Wang XJ, Salczak VR, Wisniewski S, Pote J, Gordon JS, Heyman RA, Evans RM, Roop DR 1995 Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 9:317-329
16. Tsai S, Collins SJ 1993 A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90:7153-7157
17. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689
18. Wagner RL, Apriletti JW, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor ligand-binding domain. Nature 378: 690-697
19. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha [see comments]. Nature 375:377-382
20. Hollenberg SM, Evans RM 1988 Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899-906
21. Barettino D, Vivanco Ruiz MdM, Stunnenberg HG 1994 Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13:3039-3049
22. Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P 1994 Activation function 2 (AF2) of retinoic acid receptor and 9-cis reinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF2 activity. EMBO J 13:5370-5382
23. Casanova J, Helmer E, Selmi-Ruby S, Qi JS, Au-Fliegner M, Desai-Yajnik V, Koudinova N, Yarm F, Raaka BM, Samuels HH 1994 Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol Cell Biol 14:5756-5765
24. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors [see comments]. Nature 377:454-457
25. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor [see comments]. Nature 377: 397-404
26. Glass CK, Rose DW, Rosenfeld MG 1997 Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232
27. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L 1996 Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167-1177
28. Chen JD, Li HL 1997 Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors. Crit Rev Gene Expr, in press
29. Johnson AD 1995 The price of repression. Cell 81:655-658
30. Chen JD, Umesono K, Evans RM 1996 SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93:7567-7571
31. Sande S, Privalsky ML 1996 Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol Endocrinol 10:813-825
32. Seol W, Mahon MJ, Lee YK, Moore DD 1996 Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol Endocrinol 10: 1646-1655
33. Hollenberg AN, Monden T, Madura JP, Lee K, Wondisford FE 1996 Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J Biol Chem 271:28516-28520
34. Privalsky ML, Sharif M, Yamamoto KR 1990 The viral erbA oncogene protein, a constitutive repressor in animal cells, is a hormone-regulated activator in yeast. Cell 63:1277-1286
35. Yen PM, Liu Y, Sugawara A, Chin WW 1996 Vitamin D receptors repress basal transcription and exert dominant negative activity on triiodothyronine-mediated transcriptional activity. J Biol Chem 271:10910-10916
36. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM 1996 Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103
37. Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M 1996 p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 93:11540-11545
38. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
39. Yao TP, Ku G, Zhou N, Scully R, Livingston DM 1996 The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 93:10626-10631
40. Wolffe AP 1997 Sinful repression. Nature 387:16-17
41. Pazin MJ, Kadonaga JT 1997 What's up and down with histone deacetylation and transcription? Cell 89:325-328
42. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM 1997 Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380
43. Laherty CD, Yang W-M, Sun J-M, Davie JR, Seto E, Eisenman RN 1997 Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-356
44. Kadosh D, Struhl K 1997 Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters. Cell 89:365-371
45. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG 1997 A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression [see comments]. Nature 387:43-48
46. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE 1997 Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-347
47. DiRenzo J, Soderstrom M, Kurokawa R, Ogliastro MH, Ricote M, Ingrey S, Horlein A, Rosenfeld MG, Glass CK 1997 Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol Cell Biol 17: 2166-2176
48. Alland L, Muhle R, Hou Jr H, Potes J, Chin L, Schreiber-Agus N, DePinho RA 1997 Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression [see comments]. Nature 387:49-55
49. Downes M, Burke LJ, Bailey PJ, Muscat GE 1996 Two receptor interaction domains in the corepressor, N-CoR/ RIP13, are required for an efficient interaction with ReverbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res 24:4379-4386
50. Zamir I, Harding HP, Atkins GB, Horlein A, Glass CK, Rosenfeld MG, Lazar MA 1996 A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol 16:5458-5465
51. Zamir I, Zhang J, Lazar MA 1997 Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev 11:835-846
52. Lala DS, Mukherjee R, Schulman IG, Koch SS, Dardashti LJ, Nadzan AM, Croston GE, Evans RM, Heyman RA 1996 Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature 383:450-453
53. Schulman IG, Chakravarti D, Juguilon H, Romo A, Evans RM 1995 Interactions between the retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation. Proc Natl Acad Sci USA 92:8288-8292
54. Ayer DE, Lawrence QA, Eisenman RN 1995 Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776
55. Taunton J, Hassig CA, Schreiber SL 1996 A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p [see comments]. Science 272:408-411
56. Yang WM, Inouye C, Zeng Y, Bearss D, Seto E 1996 Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 93: 12845-12850
57. Umesono K, Murakami KK, Thompson CC, Evans RM 1991 Direct repeats as selective response elements for the thyroid hormone induced gene expression through a common responsive element. Cell 65:1255-1266
58. Halleck MS, Pownall S, Harder KW, Duncan AM, Jirik FR, Schlegel RA 1995 A widely distributed putative mammalian transcriptional regulator containing multiple paired amphipathic helices, with similarity to yeast SIN3. Genomics 26:403-406
59. Durfee T, Becherer K, Chen PL, Yen SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ 1993 The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 7:555-569